Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov enrollment closed later-stage tilt small index

Juvenile Rheumatoid Arthritis: later-stage trial registry

A small indexed set (4 trials) with no open enrollment listed right now.

Corpus placement: #4,115 of 28,707 conditions by registered trial count.

4 US clinical trials · none currently recruiting · #4,115 of 28,707 conditions by registered trial count

Juvenile Rheumatoid Arthritis: 4 US clinical trials tracked, none currently recruiting.

Juvenile Rheumatoid Arthritis is the subject of 4 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 2 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), running 1 of these trials.

Enrollment posture brief

Registry condition juvenile-rheumatoid-arthritis

OPEN 0 | RECR 0% | LATE 2 | EARLY 0 | RANK #4115 | SPON 1

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Juvenile Rheumatoid Arth (th…0%
Open-enrollment share among volume-matched conditions near Juvenile Rheumatoid Arthritis

Juvenile Rheumatoid Arthritis has no open enrollment in this registry pull (4 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Juvenile Rheumatoid Arthritis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Juvenile Rheumatoid Arthritis is recruiting below its size-band peers.

    0 of 4 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 31Phase 41

Phase Distribution

PhaseTrial count
Phase 3 1
Phase 4 1

Named interventions

Most-linked intervention names on Juvenile Rheumatoid Arthritis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

methotrexate - etanercept - prednisolone arm Drug
1 trials
Calcium and cholecalciferol Dietary supplement
1 trials
Calcium Dietary supplement
1 trials
Community Resource Specialist Other
1 trials
Resource sheets Other
1 trials
methotrexate Drug
1 trials
Nurse Navigator Other
1 trials
Cholecalciferol Dietary supplement
1 trials

US sites by state

Facility locations filed on Juvenile Rheumatoid Arthritis trials. A trial with sites in several states counts in each.

Ohio 2 trials
Massachusetts 2 trials
Washington 1 trials
Utah 1 trials
Texas 1 trials
Oklahoma 1 trials
New York 1 trials
New Jersey 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Juvenile Rheumatoid Arthritis page

4 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Juvenile Rheumatoid Arthritis condition card totals 4 registered trials; most-linked intervention methotrexate - etanercept - prednisolone arm; top US site state Ohio. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.